FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Phosphate Injection
Status: Currently in Shortage
»Date first posted: 08/22/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Reverified 04/23/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Phosphorus 15 mmol/mL, 5 mL, Sodium 20 mEq/5mL vials (NDC 63323-170-05) Available Check wholesalers for inventory Demand increase for the drug
Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL (NDC 63323-170-15) Available Check wholesalers for inventory Demand increase for the drug

Hospira, Inc. (Revised 04/25/2018)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
3 mmol/mL, 15 mL vial (NDC 0409-7391-72) Estimated next delivery and Estimated recovery: 2019 Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English